A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices
β Scribed by Shields, R.; Jenkins, S.A.; Baxter, J.N.; Kingsnorth, A.N.; Ellenbogen, S.; Makin, C.A.; Gilmore, I.; Morris, A.I.; Ashby, D.; West, C.R.
- Book ID
- 122938389
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 864 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Somatostatin and endoscopic sclerotherapy are widely used in the treatment of acute variceal bleeding. Although objective evidence does exist about the advantages of either treatment, data comparing both procedures are scarce. In order to compare the effectiveness and safety of somatostatin and scle
This trial was carried out to assess the value of propranolol for the prevention of recurrent variceal bleeding in patients with well-compensated cirrhosis. We also compared propranolol therapy to long-term injection sclerotherapy. One hundred and eight patients, in whom the original variceal hemorr
trials have shown that somatostatin (SMT) is as effective as sclerotherapy in the treatment of acute variceal bleeding and that the combination of both treatments is more effective than sclerotherapy alone. To assess whether the addition of sclerotherapy improves the efficacy of SMT alone, all patie